LNAI
Lunai Bioworks Inc.
NASDAQ: LNAI · HEALTHCARE · BIOTECHNOLOGY
$0.33
-0.81% today
Updated 2026-04-30
Market cap
$11.19M
P/E ratio
—
P/S ratio
70,327.55x
EPS (TTM)
$-7.56
Dividend yield
—
52W range
$0 – $4
Volume
24.1M
Lunai Bioworks Inc. (LNAI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — |
| Cost of revenue | $391416.00 | — | — | — | $129094.00 |
| Gross profit | $-391416.00 | — | $0.00 | $0.00 | $-129094.00 |
| Gross margin | — | — | — | — | — |
| R&D | $15.54M | $8.37M | $4.17M | $2.71M | $537428.00 |
| SG&A | — | $14.33M | $15.32M | $24.56M | $17.88M |
| Operating income | $-23.40M | $-116.08M | $-38.56M | $-81.64M | $-18.55M |
| Operating margin | — | — | — | — | — |
| EBITDA | $-26.08M | $-112.94M | $-38.86M | $-85.87M | $-18.42M |
| EBITDA margin | — | — | — | — | — |
| EBIT | $-26.47M | $-113.06M | $-38.98M | $-85.99M | $-18.55M |
| Interest expense | $379608.00 | $372844.00 | $706964.00 | $2.43M | $725684.00 |
| Income tax | $-125276.00 | $34.00 | — | — | — |
| Effective tax rate | 0.5% | -0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-26.72M | $-113.43M | $-39.68M | $-88.43M | $-178.01M |
| Net income growth (YoY) | — | -324.5% | +65.0% | -122.8% | -101.3% |
| Profit margin | — | — | — | — | — |